| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 29, 2024 |
| Accession Number: | 0001193125-24-015556 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 29, 2024 |
| Accession Number: | 0001193125-24-015556 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
SC 13D - NantHealth, Inc. (0001566469) (Subject)
SC 13D - NantHealth, Inc. (0001566469) (Subject)
15-12G - NantHealth, Inc. (0001566469) (Filer)
8-K - NantHealth, Inc. (0001566469) (Filer)
EFFECT - NantHealth, Inc. (0001566469) (Filer)
4 - NantHealth, Inc. (0001566469) (Issuer)
3 - NantHealth, Inc. (0001566469) (Issuer)
3 - NantHealth, Inc. (0001566469) (Issuer)
Jerry Magin, Neil Carpenter, and Arlyn Small join leadership team to drive next-level company growth NantHealth, Inc. (NASDAQ:NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the appointments of Jerry Magin as Senior Vice President of Global Sales and Marketing; Neil Carpenter as Senior Vice President of Strategy and Arlyn Small as Senior Vice President of Human Resources, to its executive leadership team. Jerry Magin has more than 25 years of industry experience building and scaling high-performing marketing, business development, sales and operational teams. In his role as Senior Vice President of Globa
NantHealth, Inc. (NASDAQ:NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the appointment of Tiffany Avery, MD, MPH, as Chief Medical Officer. In her new position, Dr. Avery will be responsible for providing clinical strategic direction and guiding the development and deployment of NantHealth's Eviti decision support platform and other innovative products and services. "Appointing Dr. Avery to our leadership team is an incredibly valuable addition to the organization, particularly as we expand into areas like population health and additional disease states for Eviti," said Ron Louks, Chief Operating Officer, NantH
HITRUST Certification validates NantHealth's commitment to aligning with key regulations and protecting sensitive information NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its Eviti Connect solution has earned Certified status for information security by HITRUST. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that NantHealth's Eviti Connect solution has met key regulations and industry-defined requirements for managing risk. This achievement places NantHealth in an elite group of organizations worldwide that have earned this certification. "Organizations like ours are under c
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the entry into a credit agreement for a new senior secured term loan in an aggregate principal amount of $22.5 million. The company intends to use the proceeds to continue funding its existing businesses and for general corporate purposes. The Term Loan Facility was funded by two existing NantHealth investors: Highbridge Capital Management, LLC and Nant Capital, LLC. "The era of digital medicine and augmented intelligence has finally arrived. NantHealth has stood at the forefront of driving evidence based, low cost care to treat
Meridian 2023 is a look into the future of network monitoring, centered around simplification The OpenNMS Group, Inc., a subsidiary of NantHealth, Inc. (NASDAQ:NH), today announced the release of OpenNMS Meridian 2023. With this major release, the fully open source Meridian product, which is the optimized and supported version of the OpenNMS platform curated by The OpenNMS Group, Inc. (OpenNMS) for production environments, now features cloud services, containerization benefits, and other advancements. "The cloud capabilities we're launching with Meridian 2023 bring us a huge step closer to our vision of a world where monitoring just happens," said David Hustace, President, Founderat OpenN
Q3 2022 Financial and Operational Highlights: Total net revenue was $16.6 million Gross profit was $9.7 million, or 58% of total revenue The company's Eviti Connect platform earned full URAC accreditation for Health Utilization Management, through 2025 Maryland Physicians Care signed a two-year renewal agreement for Eviti Connect for Autoimmune Diseases Post quarter end: Secured 3-year contract extension with large national commercial insurer that provides coverage to more than two million Medicaid members across multiple states. Expanded contract now includes formulary redirection NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help busi
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-942-2493 from the U.S. or Canada, or 212-231-2931 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks ec
Q2 2022 Financial and Operational Highlights: Total net revenue was $16.5 million Gross margin was 55% of total revenue NantHealth products won three industry awards, one from MedTech Breakthrough and two from Spring Digital Health NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2022. "For the 2022 second quarter, we reported net revenue of $16.5 million, representing the third consecutive quarter of top-line growth," said Ron Louks, Chief Operating Officer, NantHealth. "We are pleased to note that our overall gro
Gainers CohBar, Inc. (NASDAQ:CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline. HeartCore Enterprises, Inc. (NASDAQ:HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results. Ocean Biomedical, Inc. (NASDAQ:OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer. Shuttle Pharmace
Gainers CohBar (NASDAQ:CWBR) stock rose 192.9% to $4.54 during Tuesday's pre-market session. The market value of their outstanding shares is at $13.1 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 50.48% to $1.55. The market value of their outstanding shares is at $21.1 million. Biocept (NASDAQ:BIOC) shares increased by 36.43% to $6.74. The market value of their outstanding shares is at $3.9 million. Finch Therapeutics Gr (NASDAQ:FNCH) shares rose 14.39% to $0.33. The market value of their outstanding shares is at $15.7 million. Icosavax (NASDAQ:ICVX) shares moved upwards by 14.23% to $8.99. The market value of their outstanding shares is at $372.4 million. IMAC Hldgs (NASD
Gainers Trevena, Inc. (NASDAQ:TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) jumped 139% to $0.9321. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company. Immuron Limited (NASDAQ:IMRN) climbed 62.9% to $3.0470 after the company announced the FDA removed the clinical hold on the New Campylobacter ETEC Therapeutic IND application. SMX (Security Matters) Public Limited Company (NASDAQ:SMX) climbed 45.1% to $1.93 after jumping around 54% on Friday. VCI Global Limited (NASDAQ:VCIG) gained 37% to $5.37. EZFill Holdings Inc. (NASDAQ:EZFL) s